International Journal of Molecular and Cellular Medicine (IJMCM)
Cellular and Molecular Biology Research Center, Babol University of Medical Sciences
شنبه 6 اردیبهشت 1404
[Archive]
دوره 13، شماره 3 - ( 4-1403 )
|
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Azar Bahadori R, Shabani D, Arjmandrad E, Kazerani M, Rohani M, Ramazani Karim Z, et al . Circulating miRNA-106b-5p As a Potential Biomarker for Coronary Artery Disease. Int J Mol Cell Med 2024; 13 (3) :325-336
URL: http://ijmcmed.org/article-1-2256-fa.html
URL: http://ijmcmed.org/article-1-2256-fa.html
Circulating miRNA-106b-5p As a Potential Biomarker for Coronary Artery Disease. مجله بین المللی سلولی و مولکولی. 1403; 13 (3) :325-336
: (837 مشاهده)
Coronary artery diseases (CAD) represent a significant global health concern and are recognized as a primary contributor to mortality on a worldwide scale. Early diagnosis of CAD is one of promising goal to manage this disorder. Recent investigations have highlighted the pivotal involvement of microRNAs (miRNAs) in diverse health conditions, notably CAD. The principal objective of this investigation was to identify appropriate miRNAs that could be employed for the early detection of CAD. In the present study, we analyzed dataset of CAD (GSE113079) and 100 differentially expressed mRNAs (DEmRNAs) were detected. The miRNAs that have a significant interaction with DEmRNAs were chosen. By computational prediction method, 5 miRNAs (miR-106b-5p, miR-20a-3p, miR-17-3p, miR-146a-5p, and miR-155-3p) were selected. Finally, we assessed the anticipated expression levels of microRNAs in CAD patients and healthy control groups. Our findings revealed a statistically significant elevation solely in the expression level of miR-106b-5p within the CAD group when compared to the control group (p>0.001). Our study demonstrated an elevation in the expression of miR-106b-5p in individuals diagnosed with CAD. This microRNA may be used as a diagnostic biomarker in patients with CAD. However, further investigations are needed to confirm these results.
نوع مطالعه: Original Article |
موضوع مقاله:
Biomarkers (diagnosis & treatment)
دریافت: 1402/9/15 | پذیرش: 1403/4/17 | انتشار: 1403/6/7
دریافت: 1402/9/15 | پذیرش: 1403/4/17 | انتشار: 1403/6/7
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
